Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07653464 · ClinicalTrials.gov registry record · Early Phase 1
Interplay of Central and Peripheral Vascular Effects of Insulin in Obesity
A Early Phase 1 study, sponsored by University of Missouri-Columbia.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 64
- Enrollment target
NCT07653464: Clinical Trial Early Phase 1 study, sponsored by University of Missouri-Columbia.
NCT07653464 is a Early Phase 1 study that has not yet begun recruiting, run by University of Missouri-Columbia. The registered enrollment target is 64 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (21% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07653464, a Early Phase 1 study, has not yet begun recruiting, sponsored by University of Missouri-Columbia.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 64 participants
- Enrollment target
Study Summary
In the present study, we seek to determine the impact of obesity with insulin resistance on the neurovascular response to brain insulin stimulation.
Primary Outcome
MSNA burst incidence (bursts/100 heart beats)
Interventions
- DRUG human insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2026-08 |
| Est. Completion | 2032-06 |
| Phase | Early Phase 1 |
What is known before NCT07653464 opens enrollment
NCT07653464 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (21% higher).
The record links to 0 conditions, and to 1 intervention - of which human insulin is the first listed.
NCT07653464 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07653464 about?
NCT07653464 is a clinical study titled "Interplay of Central and Peripheral Vascular Effects of Insulin in Obesity". In the present study, we seek to determine the impact of obesity with insulin resistance on the neurovascular response to brain insulin stimulation.
What is the current status of trial NCT07653464?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 64 participants. The study started on 2026-08. Estimated completion is 2032-06.
What interventions are being tested in trial NCT07653464?
The interventions under investigation include: human insulin (DRUG).
Who is sponsoring clinical trial NCT07653464?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07653464's enrollment target sits among peer trials
64 377th of 2000 higher than 1,613 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia